169 related articles for article (PubMed ID: 31490228)
1. A 10-year follow-up of a patient affected by myotonic dystrophy type 1 with implantable cardioverter-defibrillator implanted for secondary prevention.
De Ambroggi G; Ali H; Cappato R; Sansone VA; De Ambroggi L
J Cardiovasc Med (Hagerstown); 2020 Feb; 21(2):150-152. PubMed ID: 31490228
[No Abstract] [Full Text] [Related]
2. End-of-life of implantable defibrillator: are we certain it should always be replaced?
Stazi F
J Cardiovasc Med (Hagerstown); 2018 Feb; 19 Suppl 1():e116-e119. PubMed ID: 29538158
[No Abstract] [Full Text] [Related]
3. Progress in implantable cardioverter-defibrillator therapy: Advancement beyond technology alone.
Bhakta D; Foreman LD
Trends Cardiovasc Med; 2015 Oct; 25(7):612-3. PubMed ID: 25776986
[No Abstract] [Full Text] [Related]
4. Cardiovascular manifestations of myotonic dystrophy.
Wahbi K; Furling D
Trends Cardiovasc Med; 2020 May; 30(4):232-238. PubMed ID: 31213350
[TBL] [Abstract][Full Text] [Related]
5. Mortality Implications of Appropriate Implantable Cardioverter Defibrillator Therapy in Secondary Prevention Patients: Contrasting Mortality in Primary Prevention Patients From a Prospective Population-Based Registry.
Almehmadi F; Porta-Sánchez A; Ha ACT; Fischer HD; Wang X; Austin PC; Lee DS; Nanthakumar K
J Am Heart Assoc; 2017 Aug; 6(8):. PubMed ID: 28862957
[TBL] [Abstract][Full Text] [Related]
6. Impact of Chronic Total Coronary Occlusion on Recurrence of Ventricular Arrhythmias in Ischemic Secondary Prevention Implantable Cardioverter-Defibrillator Recipients (VACTO Secondary Study): Insights From Coronary Angiogram and Electrogram Analysis.
Nombela-Franco L; Iannaccone M; Anguera I; Amat-Santos IJ; Sanchez-Garcia M; Bautista D; Calvelo MN; Di Marco A; Moretti C; Pozzi R; Scaglione M; Cañadas V; Sandin-Fuentes M; Arenal A; Bagur R; Perez-Castellano N; Fernandez-Perez C; Gaita F; Macaya C; Escaned J; Fernández-Lozano I
JACC Cardiovasc Interv; 2017 May; 10(9):879-888. PubMed ID: 28473110
[TBL] [Abstract][Full Text] [Related]
7. The implantable cardioverter-defibrillator: An update.
Miller JD; Yousuf O; Berger RD
Trends Cardiovasc Med; 2015 Oct; 25(7):606-11. PubMed ID: 25912255
[TBL] [Abstract][Full Text] [Related]
8. Sex differences in implantable cardioverter-defibrillator implantation indications and outcomes: lessons from the Nationwide Israeli-ICD Registry.
Amit G; Suleiman M; Konstantino Y; Luria D; Kazatsker M; Chetboun I; Haim M; Gavrielov-Yusim N; Goldenberg I; Glikson M;
Europace; 2014 Aug; 16(8):1175-80. PubMed ID: 24554524
[TBL] [Abstract][Full Text] [Related]
9. Low Prevalence of Inappropriate Shocks in Patients With Inherited Arrhythmia Syndromes With the Subcutaneous Implantable Defibrillator Single Center Experience and Long-Term Follow-Up.
Rudic B; Tülümen E; Berlin V; Röger S; Stach K; Liebe V; El-Battrawy I; Dösch C; Papavassiliu T; Akin I; Borggrefe M; Kuschyk J
J Am Heart Assoc; 2017 Oct; 6(10):. PubMed ID: 29042423
[TBL] [Abstract][Full Text] [Related]
10. Subcutaneous implantable cardioverter defibrillator indication in prevention of sudden cardiac death in difficult clinical situations: A French expert position paper.
Probst V; Boveda S; Sadoul N; Marquié C; Chauvin M; Mondoly P; Gras D; Jacon P; Defaye P; Leclercq C; Anselme F
Arch Cardiovasc Dis; 2020 May; 113(5):359-366. PubMed ID: 32334981
[TBL] [Abstract][Full Text] [Related]
11. Prophylactic implantable cardioverter defibrillator treatment in patients with end-stage heart failure awaiting heart transplantation.
Fröhlich GM; Holzmeister J; Hübler M; Hübler S; Wolfrum M; Enseleit F; Seifert B; Hürlimann D; Lehmkuhl HB; Noll G; Steffel J; Falk V; Lüscher TF; Hetzer R; Ruschitzka F
Heart; 2013 Aug; 99(16):1158-65. PubMed ID: 23813845
[TBL] [Abstract][Full Text] [Related]
12. Effectiveness of single- vs dual-coil implantable defibrillator leads: An observational analysis from the SIMPLE study.
Neuzner J; Hohnloser SH; Kutyifa V; Glikson M; Dietze T; Mabo P; Vinolas X; Kautzner J; O'Hara G; Lawo T; Brachmann J; VanErven L; Gadler F; Appl U; Wang J; Connolly SJ; Healey JS
J Cardiovasc Electrophysiol; 2019 Jul; 30(7):1078-1085. PubMed ID: 30945798
[TBL] [Abstract][Full Text] [Related]
13. Implantable Defibrillator Timing Windows: When Coincidence Can Be Confusing.
Jackson N; Viswanathan K; Cameron D; Nair K
Circ Arrhythm Electrophysiol; 2016 Mar; 9(3):e002876. PubMed ID: 26902146
[No Abstract] [Full Text] [Related]
14. Implantable Cardioverter Defibrillator Lead Survival in Athletic Patients.
Link MS; Sullivan RM; Olshansky B; Cannom D; Berul CI; Hauser RG; Heidbuchel H; Jordaens L; Krahn AD; Morgan J; Patton KK; Saarel EV; Wilkoff BL; Li F; Dziura J; Brandt C; Barth C; Lampert R
Circ Arrhythm Electrophysiol; 2021 Mar; 14(3):e009344. PubMed ID: 33724879
[No Abstract] [Full Text] [Related]
15. ICD implantation for secondary prevention in patients with ventricular arrhythmia in the setting of acute cardiac ischemia and a history of myocardial infarction.
van Dijk VF; Quast ABE; Schaap J; Balt JC; Kelder JC; Wijffels MCEF; de Groot JR; Boersma LVA
J Cardiovasc Electrophysiol; 2020 Feb; 31(2):536-543. PubMed ID: 31944462
[TBL] [Abstract][Full Text] [Related]
16. An unusual cause for implantable cardioverter-defibrillator extraction.
Abuomara HZ; Cassidy C; Brack M; Zaidi A
Europace; 2019 Mar; 21(3):458. PubMed ID: 30239693
[No Abstract] [Full Text] [Related]
17. Electrocardiographic risk stratification in patients with a primary prophylactic implantable cardioverter defibrillator: can future arrhythmias correlating with sudden cardiac death be predicted?
Zabel M; Friede T
Europace; 2024 Jun; 26(6):. PubMed ID: 38758091
[TBL] [Abstract][Full Text] [Related]
18. Epicardial implantable cardioverter-defibrillator system placed in a 4.9-kg infant.
Bryant R; Aboutalebi A; Kim JJ; Kertesz N; Morales DL
Tex Heart Inst J; 2011; 38(4):421-3. PubMed ID: 21841874
[TBL] [Abstract][Full Text] [Related]
19. When to consider an implantable cardioverter defibrillator following myocardial infarction?
Szwejkowski BR; Wright GA; Connelly DT; Gardner RS
Heart; 2015 Dec; 101(24):1996-2000. PubMed ID: 26526420
[TBL] [Abstract][Full Text] [Related]
20. Multicentre experience with the second-generation subcutaneous implantable cardioverter defibrillator and the intermuscular two-incision implantation technique.
Migliore F; Mattesi G; De Franceschi P; Allocca G; Crosato M; Calzolari V; Fantinel M; Ortis B; Facchin D; Daleffe E; Fabris T; Marras E; De Lazzari M; Zanon F; Marcantoni L; Siciliano M; Corrado D; Iliceto S; Bertaglia E; Zecchin M
J Cardiovasc Electrophysiol; 2019 Jun; 30(6):854-864. PubMed ID: 30827041
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
